Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

13.49

+0.80 (6.30%)

At close: Oct 7, 2025, 4:00 PM EDT

13.59

+0.10 (0.74%)

After-hours: Oct 7, 2025, 5:43 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Relyvrio (Sodium Phenylbutyrate and Taurursodiol)	87.37M	Log In	Log In	Log In	Log In	Upgrade
Relyvrio (Sodium Phenylbutyrate and Taurursodiol) Growth	-77.06%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
United States	87.37M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-77.06%	Log In	Log In	Log In	Log In	Upgrade